fbpx
SmiLe Incubator
  • JOIN
    • Incubator
    • e-Campus
    • Bootcamp
    • Open Lab Skåne
  • STAY
    • Incubation process
    • Labs & equipment
    • SDG Scan
    • Offices & Services
    • CEO group
    • Extra Benefits
  • SCALE
    • Alumni membership
    • Success stories
  • COLLABORATE
    • Member startups
    • Member alumni
    • Alumni
    • Industry network
    • Investor network
    • Sponsors
    • Founding partners
  • NEWS
  • EVENTS
  • SMILE
    • About SmiLe
    • Team & board
    • About the region
  • CONTACT US
  • Search
  • Menu Menu

WHERE LIFE SCIENCE STARTUPS SCALE UP

When your business is going well and it’s time to leave SmiLe, why not stay as an Alumni member, and benefit from a multitude of opportunities.

After graduating from the incubator you are eligible for our Alumni membership service for scale-ups, that gives you continued access to labs, events, media exposure, investment opportunities as well as to our dynamic community and our innovation network.

One thing we ask in return – that you contribute to our community and are active in driving it forward.

Benefits of Alumni members

  • Access to our labs and state-of-the-art instruments
  • Access to our events
  • Free media exposure
  • Access to the Business Strategy Program
  • Office space at our facilities
  • Coaching in People & Culture
  • Access to our network
  • Access to new markets

“Thank you Ebba! You and your excellent team have managed to create such a fantastic atmosphere where SmiLe and its companies generously share their knowledge and experience. It is a privilege to be part of such a great community and we look forward to continuing as an alumni.” 

Johanna Asklin, PhD
Director Of Operations at SAGA Diagnostics

 
PreviousNext

Immunovia

While at SmiLe, Immunovia gained access to a broad life science expertise, valuable infrastructure with laboratories and closeness to Lund University. Today, Immunovia has a market cap of close to 300 million EUR. They develop tools for diagnosing complex diseases and biomarker signatures specific to each disease are identified by blood tests. The first test is for early stage pancreatic cancer.

SmiLe’s internationalization experience and commercial community is crucial for a startup

Carl Borrebaeck, PhD
Founder of Immunovia

Speximo

Speximo is one of the spin-outs from Lund University. While the experts optimized the characteristics of the substance and the technology in the labs at SmiLe, the CEO developed the company being challenged and supported by Smile´s coaches and experts. Speximo business – next generation stabilization and encapsulation technology – then had such a value that a global market leader aquired the company.

At Smile I got tools and support needed to succeed and in the end make an exit

Malin Sjöö, PhD
CEO of Speximo

Acrivon

Acrivon is focused on developing oncology drugs and came to SmiLe with a scientifically mature technology for identifying patients that benefit from a specific treatment. SmiLe has supported Acrivon with training, exposure and expertise to successfully build the infrastructure and discovery efforts.

SmiLe has been instrumental for the growth of Acrivon.

Kristina Masson, PhD
Founder of Acrivon

CONTACT US

info@smileincubator.life

SmiLe Incubator
Medicon Village
Scheeletorget 1
223 63 Lund
Sweden

STAY UP TO DATE

Sign up to our newsletter
Download our Press kit
Read our Privacy Policy

FOLLOW US

© 2021 Copyright SmiLe Incubator
Scroll to top